GeneReach Biotechnology Past Earnings Performance
Past criteria checks 0/6
GeneReach Biotechnology's earnings have been declining at an average annual rate of -22.7%, while the Medical Equipment industry saw earnings growing at 11.3% annually. Revenues have been declining at an average rate of 5.5% per year.
Key information
-22.7%
Earnings growth rate
-23.1%
EPS growth rate
| Medical Equipment Industry Growth | 11.5% |
| Revenue growth rate | -5.5% |
| Return on equity | -17.8% |
| Net Margin | -72.6% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Does GeneReach Biotechnology (GTSM:4171) Have A Healthy Balance Sheet?
Apr 18
Will Weakness in GeneReach Biotechnology Corp.'s (GTSM:4171) Stock Prove Temporary Given Strong Fundamentals?
Feb 28We Like GeneReach Biotechnology's (GTSM:4171) Returns And Here's How They're Trending
Jan 31The GeneReach Biotechnology (GTSM:4171) Share Price Is Up 596% And Shareholders Are Delighted
Dec 27
GeneReach Biotechnology Corp.'s (GTSM:4171) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Nov 28Revenue & Expenses Breakdown
How GeneReach Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 192 | -139 | 188 | 77 |
| 31 Mar 24 | 203 | -149 | 192 | 75 |
| 31 Dec 23 | 225 | -166 | 195 | 61 |
| 30 Sep 23 | 256 | -161 | 182 | 58 |
| 30 Jun 23 | 314 | -99 | 177 | 55 |
| 31 Mar 23 | 583 | 84 | 182 | 59 |
| 31 Dec 22 | 750 | 221 | 190 | 59 |
| 30 Sep 22 | 886 | 338 | 199 | 60 |
| 30 Jun 22 | 1,063 | 411 | 201 | 59 |
| 31 Mar 22 | 1,015 | 383 | 210 | 54 |
| 31 Dec 21 | 1,012 | 377 | 208 | 57 |
| 30 Sep 21 | 1,075 | 404 | 211 | 55 |
| 30 Jun 21 | 979 | 362 | 220 | 56 |
| 31 Mar 21 | 961 | 337 | 207 | 64 |
| 31 Dec 20 | 857 | 257 | 211 | 69 |
| 30 Sep 20 | 695 | 181 | 189 | 68 |
| 30 Jun 20 | 589 | 131 | 172 | 64 |
| 31 Mar 20 | 409 | 70 | 161 | 50 |
| 31 Dec 19 | 366 | 77 | 149 | 41 |
| 30 Sep 19 | 299 | 64 | 147 | 36 |
| 30 Jun 19 | 262 | 50 | 138 | 33 |
| 31 Mar 19 | 232 | 43 | 123 | 32 |
| 31 Dec 18 | 187 | 29 | 109 | 29 |
| 30 Sep 18 | 170 | -3 | 106 | 34 |
| 30 Jun 18 | 163 | -13 | 107 | 34 |
| 31 Mar 18 | 159 | -26 | 108 | 34 |
| 31 Dec 17 | 155 | -48 | 111 | 33 |
| 30 Sep 17 | 149 | -39 | 115 | 30 |
| 30 Jun 17 | 151 | -43 | 115 | 32 |
| 31 Mar 17 | 148 | -48 | 115 | 33 |
| 31 Dec 16 | 150 | -39 | 112 | 35 |
| 30 Sep 16 | 154 | -28 | 106 | 35 |
| 30 Jun 16 | 155 | -12 | 103 | 34 |
| 31 Mar 16 | 155 | -18 | 102 | 36 |
| 31 Dec 15 | 149 | -25 | 103 | 40 |
| 30 Sep 15 | 139 | -22 | 105 | 43 |
| 30 Jun 15 | 148 | -31 | 111 | 45 |
| 31 Mar 15 | 139 | -31 | 110 | 44 |
| 31 Dec 14 | 134 | -30 | 107 | 42 |
| 30 Sep 14 | 129 | -40 | 102 | 44 |
| 30 Jun 14 | 106 | -49 | 97 | 40 |
| 31 Mar 14 | 106 | -55 | 98 | 35 |
| 31 Dec 13 | 96 | -58 | 94 | 30 |
Quality Earnings: 4171 is currently unprofitable.
Growing Profit Margin: 4171 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4171 is unprofitable, and losses have increased over the past 5 years at a rate of 22.7% per year.
Accelerating Growth: Unable to compare 4171's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4171 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.7%).
Return on Equity
High ROE: 4171 has a negative Return on Equity (-17.83%), as it is currently unprofitable.